Treatment
Amoxicillin clinical trials
We’re tracking 58 recruiting studies that include Amoxicillin, each written for real people, not researchers, below.
Recruiting studies
- NCT05926804Recruiting
Screening and treatment for Helicobacter pylori in teens
This trial checks teenagers for a long-lasting H. pylori stomach infection and then treats those who need it. It may help prevent ongoing stomach problems from the infection and compare outcomes between treated and non-treated groups.
CoyhaiqueAges 14–18 - NCT06126731RecruitingPhase 1/Phase 2
Antibiotics plus enzalutamide for advanced prostate cancer
This trial tests whether adding specific antibiotics (amoxicillin, metronidazole, vancomycin, ciprofloxacin) to enzalutamide can help treat advanced prostate cancer that has stopped responding to other treatments. It aims to see if changing gut bacteria can make the cancer therapy work better.
BellinzonaAges 18 years+ - NCT05761080RecruitingPhase 4
Care plan tested for kids with complicated appendicitis
This trial tests a “fast-track” recovery care plan for children after surgery for complicated appendicitis. It may help kids recover faster and with fewer problems after a laparoscopic appendectomy.
Barcelona, BarcelonaAges 2–17 - NCT05248620Recruiting
Antibiotics to prevent infections in hemodialysis catheters
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
Copenhagen, Capital RegionAges 18 years+ - NCT06020716RecruitingPhase 4
Antibiotics for chronic wet cough in toddlers
This study tests whether the antibiotic Augmentin helps children aged 9 months to 3 years with long-lasting wet cough (more than 4 weeks). It aims to find better ways to treat and understand this common problem in toddlers.
ÅlesundAges 9 months–3 years - NCT07492134RecruitingPhase 2
Antibiotics vs placebo for mild diverticulitis
This study tests whether antibiotics are necessary for mild diverticulitis or if a placebo works just as well. Participants are treated in the emergency department and followed using a smartphone app.
Nashville, TennesseeAges 18–90 - NCT05061732RecruitingPhase 4
Treatment and follow-up study for Helicobacter pylori infection
This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07451171RecruitingPhase 2
Comparing antibiotics for gut bacteria in children
This study compares three different antibiotics to treat small intestine bacterial overgrowth (an overgrowth of bacteria in the gut) in children in Bangladesh. It aims to find which antibiotic works best.
DhakaAges 1–2 - NCT07122024RecruitingPhase 4
Testing a dual therapy for H. pylori treatment
This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.
Hangzhou, ZhejiangAges 18–65 - NCT06510010RecruitingPhase 2
Chemo plus H. pylori treatment for advanced stomach cancer
This trial tests whether adding H. pylori bacteria treatment to standard chemotherapy (before and after surgery) can improve outcomes for people with locally advanced stomach cancer. It combines oxaliplatin and S-1 chemo with antibiotics to clear the infection.
GuangzhouAges 18–75 - NCT04552080RecruitingPhase 4
Antibiotics around sinus and bone graft implants to prevent problems
This trial studies whether taking antibiotics through the body (systemic antibiotics) after sinus-lift and bone-graft dental implant surgery can reduce post-surgery complications and improve patient comfort. It compares outcomes that matter to patients after implant placement using guided bone regeneration and a sinus floor elevation.
GrazAges 21 years+ - NCT07232095RecruitingPhase 4
7-Day treatment for H. pylori with new acid blocker and antibiotics
This trial tests a 7-day combination of vonoprazan, high-dose amoxicillin, and bismuth to treat Helicobacter pylori infection in people who have never been treated for it before. The goal is to see if this short course is effective and safe for curing the infection.
Nanjing, JiangsuAges 18–70 - NCT06959368RecruitingPhase 4
New H. pylori treatment vs standard triple therapy
This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.
Hyderabad, TelanganaAges 18–80 - NCT06561698RecruitingPhase 4
High-dose dual therapy vs minocycline quadruple therapy for H. pylori
This trial compares two treatments for H. pylori infection: a high-dose two-drug regimen and a four-drug regimen containing minocycline. It aims to find which is more effective and better tolerated.
Hebi, HenanAges 18–70 - NCT04047849RecruitingPhase 4
Antibiotics for early water breaking before 23 weeks
This trial studies whether taking antibiotics can help in pregnancies where the “water” broke early (before 23 weeks) but you don’t have a fever. It aims to reduce complications while keeping both mother and baby as safe as possible.
Baton Rouge, LouisianaAges 18 years+ - NCT04728516RecruitingPhase 4
Eradication treatment versus acid pills to prevent GI bleeding
This trial compares a “dual eradication therapy” (to get rid of H. pylori in the stomach) versus usual acid-reducing pills (PPIs) to lower the risk of gastrointestinal bleeding in people with recent heart artery disease treated with a stent. It may help by reducing stomach infection-related bleeding while you continue needed heart medicines.
Bozhou, AnhuiAges 18 years+ - NCT05302531RecruitingPhase 1
Testing high-absorption antibiotics for short-bowel syndrome
This early (Phase 1) study tests how well certain antibiotics get absorbed in the body when you have short-bowel syndrome. It may help doctors choose antibiotics that work better through the mouth for people with this digestion problem.
Vandœuvre-lès-Nancy, LorraineAges 18 years+ - NCT06010719RecruitingPhase 4
Azithromycin for severe malnutrition in children
This study tests whether adding the antibiotic azithromycin to standard nutritional care helps young children with severe acute malnutrition recover better. It is for children aged 6 to 59 months in Burkina Faso who have uncomplicated malnutrition and are not currently on antibiotics.
Nouna, KossiAges 6 months–4.9 years - NCT06061484Recruiting
Modified feeding for severe malnutrition in young children
This trial tests a modified feeding plan for children under 5 with severe acute malnutrition who are not sick enough to need hospital care. It aims to see if a different dosing of therapeutic food helps them recover better at home.
Sekota, AmharaAges 6 months–4.9 years - NCT06197308RecruitingEarly Phase 1
Testing a mouth bacteria treatment for PSC
This study tests whether a treatment made from mouth bacteria can help people with primary sclerosing cholangitis (PSC). It aims to see if it's safe and improves health.
Minneapolis, MinnesotaAges 18–76 - NCT06396078RecruitingPhase 4
Antibiotics for Early Water Breaking Before Delivery
This study tests whether giving antibiotics to pregnant people with early water breaking (PPROM) before delivery improves outcomes. It aims to prevent infections and protect both parent and baby while waiting for delivery.
Columbus, OhioAges 18 years+ - NCT06406114RecruitingPhase 2
Better Allergy Testing for Cephalosporin Antibiotics
This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.
Scottsdale, ArizonaAges 18–70 - NCT06409884Recruiting
Amoxicillin allergy testing trial
This trial is testing a new way to diagnose allergies to amoxicillin, a common antibiotic. It may help people who think they might be allergic to amoxicillin find out for sure.
Edegem, AntwerpAges 6 years+ - NCT06733675RecruitingPhase 1
Safety study of a new antibiotic combination
This trial tests a new antibiotic called ceftibuten-ledaborbactam in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult and do not have allergies to certain antibiotics.
Lenexa, KansasAges 18–55
Common questions
- Are there clinical trials studying Amoxicillin?
- Yes. Clin2 currently lists 58 recruiting studies that include Amoxicillin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Amoxicillin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Amoxicillin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Amoxicillin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.